Featured / Symposia

Online Symposium: Prof. Osenga’s Top 2020 Federal Circuit Patent Decisions

Guest Post by Kristen Osenga

In any given year, the Federal Circuit covers a wide spectrum of issues in patent law, and 2020 was no different. Of course, a lot about 2020 was different — including seeing the Court hold (and now livestream) telephonic arguments — but most of the patent cases decided were similar in type to other years . . . a little patent-eligible subject matter, a little jurisdiction and venue, a case about infringement of standard essential patents, and a bit of deciding what the Patent Trial and Appeal Board can and cannot do. There were no real blockbuster cases in 2020 (other than maybe the Arthrex denial of rehearing, more on that later). This could be due to the pandemic, or maybe it is a sign that patent law is settling in for a bit. Of course, that does not mean the law has settled in the right place, but that is a different issue for a different day.

For today, a few cases are worth highlighting from the Federal Circuit’s 2020 patent opinions. To be clear, this is not an exhaustive review, but rather simply a short selection noting some of the more important patent cases decided last year.

Read More
Opinions

Today’s Opinions – November 7, 2019

This morning the Federal Circuit issued three precedential opinions in a patent case, a Vaccine Act case, and a Merit Systems Protection Board case. The court also issued three nonprecedential opinions in a patent case, a Merit Systems Protection Board case, and a case dismissed by the Court of Federal Claims. The court also issued two nonprecedential Rule 36 judgments. Here are the introductions to the opinions and a list of the Rule 36 judgments.

Read More